A detailed history of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Commonwealth Of Pennsylvania Public School Empls Retrmt Sys holds 56,186 shares of VRTX stock, worth $25.3 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
56,186
Previous 56,682 0.88%
Holding current value
$25.3 Million
Previous $26.6 Million 1.64%
% of portfolio
0.17%
Previous 0.18%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$460.0 - $505.78 $228,160 - $250,866
-496 Reduced 0.88%
56,186 $26.1 Million
Q2 2024

Aug 12, 2024

BUY
$392.81 - $485.53 $42,816 - $52,922
109 Added 0.19%
56,682 $26.6 Million
Q1 2024

May 08, 2024

BUY
$407.69 - $446.08 $58,707 - $64,235
144 Added 0.26%
56,573 $23.6 Million
Q4 2023

Feb 09, 2024

BUY
$343.0 - $410.68 $1.56 Million - $1.86 Million
4,534 Added 8.74%
56,429 $23 Million
Q3 2023

Nov 09, 2023

BUY
$338.18 - $362.46 $2.36 Million - $2.53 Million
6,977 Added 15.53%
51,895 $18 Million
Q2 2023

Aug 09, 2023

BUY
$314.42 - $351.91 $419,750 - $469,799
1,335 Added 3.06%
44,918 $15.8 Million
Q1 2023

May 09, 2023

BUY
$283.23 - $323.1 $54,663 - $62,358
193 Added 0.44%
43,583 $13.7 Million
Q4 2022

Feb 13, 2023

BUY
$285.76 - $321.48 $1.68 Million - $1.89 Million
5,878 Added 15.67%
43,390 $12.5 Million
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $75,029 - $83,715
274 Added 0.74%
37,512 $10.9 Million
Q2 2022

Aug 15, 2022

BUY
$234.96 - $292.55 $745,998 - $928,846
3,175 Added 9.32%
37,238 $10.5 Million
Q1 2022

May 12, 2022

BUY
$221.42 - $260.97 $476,053 - $561,085
2,150 Added 6.74%
34,063 $8.89 Million
Q4 2021

Feb 11, 2022

SELL
$177.01 - $223.45 $105,851 - $133,623
-598 Reduced 1.84%
31,913 $7.01 Million
Q3 2021

Nov 10, 2021

BUY
$181.39 - $202.99 $14,148 - $15,833
78 Added 0.24%
32,511 $5.9 Million
Q2 2021

Aug 12, 2021

SELL
$187.49 - $221.1 $14,999 - $17,688
-80 Reduced 0.25%
32,433 $6.54 Million
Q1 2021

May 12, 2021

BUY
$207.02 - $241.31 $4,347 - $5,067
21 Added 0.06%
32,513 $6.99 Million
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $1.73 Million - $2.31 Million
8,359 Added 34.64%
32,492 $7.68 Million
Q3 2020

Nov 12, 2020

BUY
$255.65 - $303.1 $2.38 Million - $2.82 Million
9,307 Added 62.77%
24,133 $6.57 Million
Q2 2020

Aug 11, 2020

SELL
$225.48 - $295.8 $361,444 - $474,167
-1,603 Reduced 9.76%
14,826 $4.3 Million
Q1 2020

May 14, 2020

SELL
$199.77 - $247.81 $26,169 - $32,463
-131 Reduced 0.79%
16,429 $3.91 Million
Q4 2019

Feb 11, 2020

BUY
$166.71 - $223.91 $14,837 - $19,927
89 Added 0.54%
16,560 $3.63 Million
Q3 2019

Nov 14, 2019

SELL
$166.23 - $187.09 $564,683 - $635,544
-3,397 Reduced 17.1%
16,471 $2.79 Million
Q2 2019

Aug 13, 2019

BUY
$164.61 - $190.37 $810,210 - $937,001
4,922 Added 32.93%
19,868 $3.64 Million
Q1 2019

May 07, 2019

BUY
$163.73 - $194.7 $164,384 - $195,478
1,004 Added 7.2%
14,946 $2.75 Million
Q4 2018

Feb 11, 2019

SELL
$151.91 - $192.21 $1.07 Million - $1.35 Million
-7,030 Reduced 33.52%
13,942 $2.31 Million
Q3 2018

Nov 08, 2018

SELL
$167.73 - $192.74 $956,731 - $1.1 Million
-5,704 Reduced 21.38%
20,972 $4.04 Million
Q2 2018

Aug 03, 2018

BUY
$145.72 - $169.96 $576,614 - $672,531
3,957 Added 17.42%
26,676 $4.53 Million
Q1 2018

May 09, 2018

BUY
$151.6 - $177.13 $14,705 - $17,181
97 Added 0.43%
22,719 $3.7 Million
Q4 2017

Feb 13, 2018

BUY
$137.28 - $155.55 $290,759 - $329,454
2,118 Added 10.33%
22,622 $3.39 Million
Q3 2017

Nov 09, 2017

BUY
$148.13 - $162.24 $3.04 Million - $3.33 Million
20,504
20,504 $3.12 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Portfolio

Follow Commonwealth Of Pennsylvania Public School Empls Retrmt Sys and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.